Horm Metab Res 2002; 34(7): 411-413
DOI: 10.1055/s-2002-33475
Short Communication
© Georg Thieme Verlag Stuttgart · New York

Circulating Levels of Ghrelin and GLP-1 are Inversely Related During Glucose Ingestion

C.  B.  Djurhuus 1 , T.  K.  Hansen 1 , C.  Gravholt 1 , L.  Ørskov 1 , H.  Hosoda 3 , K.  Kangawa 3 , J.  O. L.  Jørgensen 1 , J.  J.  Holst 2 , O.  Schmitz 1
  • 1Medical Department M (Endocrinology & Diabetes), Aarhus University Hospital and Dept. of Clinical Pharmacology, University of Aarhus, Denmark
  • 2Department of Medical Physiology, the Panum Institute, University of Copenhagen, Denmark
  • 3Department of Biochemistry, National Cardiovascular Center Research Institute, Osaka, Japan
Further Information

Publication History

Received: 7 January 2002

Accepted after revision: 19 March 2002

Publication Date:
21 August 2002 (online)

Introduction

Appetite regulation, and in particular the hypothalamic appetite-regulating network, has gained increasing interest during the past years due to the gross impact of obesity on human disease. The recent discovery of the endogenous ligand for the growth hormone secretagogue receptor (GHS-R) ghrelin [1] [2], which plays a role in reducing fat utilization and increasing body weight has been of special interest [3] [4]. When injected specifically into appetite-regulating hypothalamic nuclei in rats, hyperphagia is induced [5] [6]. Finally, ghrelin has been demonstrated to enhance gastric motility in rodents [7]. In contrast to the orexigenic actions of ghrelin, another peptide released from the gastrointestinal tract, glucagon-like peptide 1 (GLP-1), induces satiety [8] [9] [10]. Whereas a possible direct impact of ghrelin on the metabolism remains to be defined, several studies such as Ørskov et al. [11] have failed to demonstrate a direct effect of GLP-1 on insulin-stimulated glucose metabolism. Whether GLP-1 per se influences lipid metabolism remains subject to controversy [12] [13].

Since ghrelin and GLP-1 appear to have opposite effects on satiety and gastrointestinal motility, we carried out the present study to explore the impact of a classic caloric challenge - an oral glucose tolerance test (OGTT) - on the dynamics of circulating ghrelin and GLP-1 levels.

References

  • 1 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
  • 2 Wren A M, Small C J, Ward H L, Murphy K G, Dakin C L, Taheri S. et al . The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.  Endocrinology. 2000;  141 4325-4328
  • 3 Tschop M, Smiley D L, Heiman M L. Ghrelin induces adiposity in rodents.  Nature. 2000;  407 908-913
  • 4 Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K. et al . A role for ghrelin in the central regulation of feeding.  Nature. 2001;  409 194-198
  • 5 Wren A M, Small C J, Abbott C R, Dhillo W S, Seal L J, Cohen M A. et al . Ghrelin causes hyperphagia and obesity in rats.  Diabetes. 2001;  50 2540-2547
  • 6 Arvat E, Maccario M, di Vito L, Broglio F, Benso A, Gottero C. et al . Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: Comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.  J Clin Endocrinol Metab. 2001;  86 1169-1174
  • 7 Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z. et al . Ghrelin stimulates gastric acid secretion and motility in rats.  Biochem Biophys Res Commun . 2000;  276 905-908
  • 8 Flint A, Raben A, Astrup A, Holst J J. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.  J Clin Invest. 1998;  101 515-520
  • 9 Verdich C, Toubro S, Buemann B, Lysgard M J, Juul H J, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction.  Int J Obes Relat Metab Disord. 2001;  25 1206-1214
  • 10 Rodriguez d e, Navarro M, Alvarez E, Roncero I, Chowen J A, Maestre O. et al . Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.  Metabolism. 2000;  49 709-717
  • 11 Orskov L, Holst J J, Moller J, Orskov C, Moller N, Alberti K G. et al . GLP-1 does not acutely affect insulin sensitivity in healthy man.  Diabetologia. 1996;  39 1227-1232
  • 12 Villanueva-Penacarrillo M L, Marquez L, Gonzalez N, Diaz-Miguel M, Valverde I. Effect of GLP-1 on lipid metabolism in human adipocytes.  Horm Metab Res. 2001;  33 73-77
  • 13 Berlin E, Arner P, Bolinder J, Hagstrom-Toft E. Action of glucagon and glucagon-like peptide-I-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo. J.  Clin Endocrinol Metab. 2001;  86 1229-1234
  • 14 Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: Two major forms of rat ghrelin peptide in gastrointestinal tissue.  Biochem Biophys Res Commun. 2000;  279 909-913
  • 15 Orskov C, Rabenhoj L, Wettergren A, Kofod H, Hoist J J. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.  Diabetes. 1994;  43 535-539
  • 16 Cummings D E, Pumell J Q, Frayo R S, Schmidova K, Wisse B E, Weigle D S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.  Diabetes. 2001;  50 1714-1719

C. B. Djurhuus

Medical Department M (Endocrinology & Diabetes), Aarhus University Hospital ·

Norrebrogade 42 - 44 · 8000 Aarhus C · Denmark ·

Phone: + 45 (89) 49 20 71

Fax: + 45 (89) 49 20 10 ·

Email: cbd@dadlnet.dk

    >